Eosinophil-guided Reduction of Inhaled Corticosteroids
Status:
Recruiting
Trial end date:
2025-12-31
Target enrollment:
Participant gender:
Summary
Clinical trial on eosinophil-guided time-updated person-specific reduction of inhaled
corticosteroid (ICS) therapy and prophylactic azithromycin therapy in patients with severe or
very severe chronic obstructive pulmonary disease (COPD) receiving long-acting b-agonist
(LABA) / long-acting muscarinic receptor antagonists (LAMA) / ICS treatment.